Handle With Care: Syros Pharmaceuticals Inc (NASDAQ: SYRS)
Currently, there are 26.83M common shares owned by the public and among those 23.67M shares have been available to trade. The company’s stock has a 5-day price change of 12.82% and -62.12% over the past three months. SYRS shares are trading -59.79% year to date (YTD), with the 12-month market performance down to -98.57% lower. […]
Syros Pharmaceuticals Inc (NASDAQ: SYRS) Has Another Chance To Impress You
Currently, there are 26.83M common shares owned by the public and among those 23.67M shares have been available to trade. The company’s stock has a 5-day price change of 11.71% and -62.87% over the past three months. SYRS shares are trading -60.14% year to date (YTD), with the 12-month market performance down to -98.72% lower. […]
Syros Pharmaceuticals Inc (SYRS) Testing Investors’ Patience Right Now
Currently, there are 26.83M common shares owned by the public and among those 23.67M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
